Press release
Renal Insufficiency Market Set to Surge in 2025: AI Diagnostics, Wearable Dialysis, and Strategic M&As Drive Global Expansion
Renal Insufficiency Market
Emerging opportunities lie in the integration of AI-driven diagnostic platforms, the expansion of home dialysis and wearable kidney devices, and an increasing focus on personalized medicine and early intervention. Major players shaping this landscape include AstraZeneca, Bayer AG, Abbott Laboratories, Baxter International, Fresenius Medical Care, and DaVita Inc., alongside biotech innovators developing next-generation therapeutics targeting renal fibrosis and inflammation.
Download your FREE sample report: https://www.datamintelligence.com/download-sample/renal-insufficiency-market?jd
Latest Strategic Alliances and Acquisitions Steering the Renal Insufficiency Market in 2025
• AstraZeneca & Chinook Therapeutics Acquisition: AstraZeneca completed its $1.3 billion acquisition of Chinook to strengthen its portfolio in rare kidney diseases, particularly IgA nephropathy and other proteinuric renal disorders.
• Bayer & Evotec Partnership Expansion: Bayer and Evotec expanded their long-term kidney disease collaboration to co-develop precision therapies targeting chronic kidney conditions using Evotec's molecular patient data platform.
• Fresenius Medical Care & Cricket Health Merger: Fresenius invested in a strategic merger with Cricket Health and InterWell Health, forming a value-based kidney care powerhouse focused on pre-dialysis patient engagement.
• Novo Nordisk Acquires ocedurenone (KBP-5074): Novo Nordisk acquired the rights to this non-steroidal MRA for treating uncontrolled hypertension and CKD, aiming to diversify into cardiorenal diseases.
• DaVita & Google Cloud Collaboration: DaVita partnered with Google Cloud to enhance its digital transformation, leveraging AI and predictive analytics for proactive kidney care management and operational efficiency.
• Otsuka Pharmaceutical & Visterra Collaboration: Otsuka advanced its pipeline in renal diseases through a strategic alliance with Visterra to develop antibody-based therapies targeting kidney inflammation.
Game-Changing Technological Advances in 2025
AI-Powered Predictive Diagnostics: Advanced machine learning models now enable early detection of renal function decline, helping clinicians stratify CKD risk and personalize treatment regimens.
Wearable Artificial Kidney Devices: Miniaturized, wearable dialysis devices are undergoing clinical trials, offering mobility, continuous filtration, and improved quality of life for end-stage renal disease (ESRD) patients.
SGLT2 Inhibitor Evolution: New-generation SGLT2 inhibitors are being combined with GLP-1 receptor agonists and other agents to offer dual cardiorenal protection in diabetic and non-diabetic populations.
Gene Editing & Regenerative Therapies: CRISPR-based approaches and stem cell therapies are entering preclinical phases, showing potential in reversing kidney fibrosis and promoting nephron regeneration.
Remote Monitoring & Tele-Nephrology: IoT-enabled platforms allow real-time patient monitoring, medication adherence tracking, and virtual nephrology consultations, especially beneficial in rural or resource-limited settings.
Bioengineered Kidney-on-a-Chip Models: Lab-grown microfluidic kidney models are accelerating drug discovery and toxicity testing, reducing reliance on animal models and improving translational outcomes.
Targeted Anti-Fibrotic Therapies: Novel agents targeting TGF-β, endothelin pathways, and other pro-fibrotic markers are entering late-stage development to slow CKD progression.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=renal-insufficiency-market?jd
Regional Market Drivers Steering Renal Insufficiency Demand in 2025
North America leads the global market, fueled by a high prevalence of CKD, a strong reimbursement framework, early adoption of novel therapies like SGLT2 inhibitors, and widespread availability of both in-center and home dialysis infrastructure.
Europe follows closely, with a growing aging population, government-backed CKD screening programs, and emphasis on value-based kidney care models.
Asia-Pacific is witnessing the fastest growth, driven by rising diabetes and hypertension cases, improving healthcare access, and increasing investments in dialysis centers across countries like India, China, and Japan.
Latin America and the Middle East & Africa are emerging markets, where urbanization, lifestyle-related disease burden, and gradual improvement in nephrology care services are expanding the market footprint.
Request for 2 Days FREE Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg?jd
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Renal Insufficiency Market Set to Surge in 2025: AI Diagnostics, Wearable Dialysis, and Strategic M&As Drive Global Expansion here
News-ID: 4124189 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Chronic Bronchitis Treatment Market 2025 | Advanced Bronchodilators, Biologics & …
The chronic bronchitis treatment market is experiencing robust growth driven by key factors such as the rising prevalence of chronic obstructive pulmonary disease (COPD), increasing tobacco use, worsening air pollution, and an aging global population susceptible to respiratory diseases. Advances in treatment modalities, including long-acting bronchodilators, inhaled corticosteroids, combination therapies, and emerging novel biologics, are further propelling market expansion. Increased diagnosis rates and growing patient awareness, supported by government health…
Hepatitis B Treatment Market 2025 | Antiviral Therapies, Immunomodulators & Gene …
The Hepatitis B treatment market is steadily growing, driven by rising global prevalence, increased awareness, improved diagnostics, and advances in antiviral therapies. "Hepatitis B Treatment Market size reached US$3.57 billion in 2024 and is expected to reach US$6.47 billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025-2033," according to DataM Intelligence. Key growth drivers include broader immunization programs, routine screening, and improved access to effective…
Mycosis Fungoides Treatment Market 2025 | Immunotherapy, Phototherapy & Targeted …
The Mycosis Fungoides Treatment Market is experiencing steady growth and is driven by rising incidence rates linked to immune system dysfunction, increased utilization of effective therapeutics, widespread adoption of phototherapy, radiation therapy, and supportive care measures. Emerging opportunities in the market include advancements in chemotherapy, a rising demand for monoclonal antibodies as first-line treatments, the development of novel topical therapies, and increasing investment in research and development of targeted and…
Metrorrhagia & Abnormal Uterine Bleeding Treatment Market 2025 | Hormonal Therap …
The Metrorrhagia and broader abnormal uterine bleeding (AUB) treatment market is witnessing notable growth driven by the increasing prevalence of uterine conditions such as fibroids, polyps, endometriosis, and hormonal imbalances, coupled with rising awareness among women and healthcare providers. The expansion is bolstered by advances in pharmaceutical therapies, including hormonal treatments and antifibrinolytics, alongside minimally invasive surgical procedures like endometrial ablation and hysteroscopic myomectomy. Enhanced diagnostic technologies have further enabled…
More Releases for Renal
Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal …
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market?
The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factors…
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032.
Renal Osteodystrophy Market Overview
The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced early…
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy …
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and development…
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh …
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market?
The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in…
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period…
